Patents by Inventor Kurt Stocker

Kurt Stocker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6613324
    Abstract: Disclosed is an adhesive for gluing of biological tissue, in particular human body tissue. The adhesive contains fibrinogen, a substance capable of supplying calcium ions, blood-coagulating factor XIIIa and, as a fibrinogen-splitting substance, a snake-venom enzyme.
    Type: Grant
    Filed: May 17, 1996
    Date of Patent: September 2, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Birger Blombäck, Birgit Hessel, Per Olsson, Lennart Strömberg, Jesper Swedenborg, Kurt Stocker
  • Patent number: 6426192
    Abstract: The method relates to a method for detecting disorders in the protein C system, and in particular for determining the activated blood coagulation factor V with increased stability with respect to decomposition by activated protein C.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: July 30, 2002
    Assignee: Pentapharm AG
    Inventors: Kurt Stocker, Patrizia Gempeler-Messina, Christian Müller
  • Patent number: 5922587
    Abstract: It was found that the use of a phospholipid dependent prothrombin activator purified from the venom of snakes belonging to the Elapidae family, especially members of the Oxyuranus and Psuedonaja genera is most useful in tests for the determination of Lupus Anticoagulant. Based on this, several clotting, chromogenic and immunochromogenic tests have been developed.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 13, 1999
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker
  • Patent number: 5705198
    Abstract: It was found that the use of a phospholipid dependent prothrombin activator purified from the venom of snakes belonging to the Elapidae family, especially members of the Oxyaranus and Psuedonaja genera is most useful in tests for the determination of Lupus Anticoagulant. Based on this, several clotting, chromogenic aria immunochromogenic tests have been developped.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 6, 1998
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker
  • Patent number: 5453370
    Abstract: A method for the preparation of a phospholipid-dependent prothrombin activator from the venom of snakes belonging to the Elapidae family, the activator comprising an increased plasma clotting activity in the presence of phospholipids and calcium ions; a reduced activity in the presence of Lupus Anticoagulant; an ability to facilitate clotting in a normal clotting time in the presence of platelet poor plasma, the plasma having normal or decreased levels of factor V, VII, VIII, IX, or X; and a major band with a molecular weight of 40,000 to 60,000 daltons on an SDS gel.
    Type: Grant
    Filed: November 30, 1992
    Date of Patent: September 26, 1995
    Assignee: Pentapharm AG
    Inventors: Douglas A. Triplett, Kurt Stocker
  • Patent number: 5322839
    Abstract: The protein fraction from Leguminosae seeds, which is characterized by at least one band in polyacrylamide gel electrophoresis with sodium dodecyl sulfate, by relative molecular masses from 3,000 to 30,000 g/mole, by a content of total nitrogen of 14 to 20% and amino nitrogen of 1 to 2% related to the protein content and by further parameters defined in claim 1, is appropriate for the care of skin and for the treatment of inflammatory skin diseases, whereby the protein fraction is generally used as a concentrate of active substances or e.g. as a cream, lotion, emulsion, gel, face mask, powder or plaster.
    Type: Grant
    Filed: September 11, 1992
    Date of Patent: June 21, 1994
    Assignee: Pentapharm AG
    Inventors: Rainer Voegeli, Kurt Stocker, Christian Mueller